Oxford Nanopore Technologies /£ONT

07:00
03:10
23:15
19:25
15:30
1D1W1MYTD1Y5YMAX

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc, trading under the ticker ONT, operates in the biotechnology sector, focusing on the development of nanopore technology for DNA and RNA sequencing. Founded in 2005 and publicly listed, the company's innovative technology facilitates real-time, scalable, and accessible biological research, with applications ranging from healthcare to environmental science. Based in the UK, Oxford Nanopore has revolutionized the approach to molecular analysis by providing a direct and electric characterization of single molecules.

Ticker

£ONT

Primary listing

LSE

Industry

Life Sciences Tools & Services

Employees

1,382

ISIN

GB00BP6S8Z30

ONT Metrics

BasicAdvanced
£1.1B
-
-£0.16
0.91
-

What the Analysts think about ONT

Analyst ratings (Buy, Hold, Sell) for Oxford Nanopore Technologies stock.

Bulls say / Bears say

Oxford Nanopore Technologies reported an 8% increase in revenue to £183.2 million in 2024, driven by strong demand in Applied Industrial, BioPharma, and Clinical segments. (morningstar.co.uk)
The company achieved a gross margin increase of 420 basis points to 58% in 2024, reflecting improvements across its product portfolio. (morningstar.co.uk)
Oxford Nanopore has set a target to achieve adjusted EBITDA breakeven by 2027 and cash flow positivity by 2028, indicating a clear path toward profitability. (morningstar.co.uk)
The company reported a pretax loss of £140.0 million in 2024, only a slight improvement from the previous year's loss of £149.8 million, indicating ongoing financial challenges. (morningstar.co.uk)
Oxford Nanopore's shares have fallen 85% from their 2021 peak, making it a potential takeover target and reflecting investor concerns about its market position. (ft.com)
The company faces challenges such as market volatility, reduced government funding, and import controls, which could hinder its growth prospects. (ft.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.

ONT Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ONT Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £ONT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs